Drug Research

Charles River Laboratories International, Inc. announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization (CDMO) expertise in High Quality...

Sanyou Biopharmaceuticals and Sinorda Biomedicine entered into a strategic cooperation agreement to advance innovative bispecific antibody drug development. The collaboration will leverage Sanyou's core technology platform for integrated R&D and preclinical development and "super-trillion innovative biologics discovery platform", and Sinorda's...

Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for...

Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet, many CDMOs fail to fully capitalize on pricing projects, risking competitiveness. To thrive, they must...

The projected worth of the Global Small Molecule Innovator CDMO Market is anticipated to surpass $76.50 billion by 2031, displaying a compounded annual growth rate (CAGR) of 6.1% during the estimated timeframe. Contract Development and Manufacturing Organizations (CDMOs) offer...

Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for...

AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site.AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to...